Elevation of the serum total and free prostate specific antigen levels after stent implantation in patients with coronary artery disease

Swiss Medical Weekly

Volumn 139, Issue 45-46, 2009, Pages 672-675

  Ozcan, Turkay ^a   Bozlu, Murat ^a   Muslu, Necati ^a   Gozukara, Kerem Han ^a   Seyis, Sabri ^a   Akcay, Burak ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Coronary artery disease; Prostate specific antigen; Stent implantation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CORONARY STENT; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SERUM;

EID: 70449659583     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Shah JB, Reese AC, McKiernan JM, Benson MC. PSA updated: still relevant in the new millennium? Eur Urol. 2005;47: 427-432
2. Oesterling JE, Rice DC, Glenski WJ, Bergstrahl EJ. Effect of cystoscopy, prostate biopsy and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology. 1993;42:276-282 (Pubitemid 23270933)
3. Long RL, Giri S, Diver S, Duddy L, McKeown D, Moran K. Effect of prostate manupilation on the serum levels of complexed prostate-specific antigen and total prostate-specific antigen. Int J Urol. 2006;13:947-950 (Pubitemid 44049923)
4. Patané S, Marte F. Prostate-specific antigen kallikrein: from prostate to cardiovascular system. Eur Heart J. 2009;30: 1169-1170
5. Koller-Strametz J, Fritzer M, Gwechenberger M, Geppert A, Heinz G, Haumer M, et al. Elevation of prostate-specific markers after cardiopulmonary resuscitation. Circulation. 2000;102: 290-293 (Pubitemid 30457578)
6. Koreny M, Koller-Strametz J, Geppert A, Karth GD, Heinz G, Maurer G, et al. Elevation of prostatic merkers following cardiogenic shock. Intensive Care Med. 2001;27:447. (Pubitemid 32249994)
7. Hagood PG, Para RO, Rauscher JA. Nontraumatic elevation of prostate specific antigen following cardiac surgery and extra-corporeal cardiopulmonary bypass. J Urol. 1994;152:2043-2045
8. Netto NR, Lima ML, Guedes MA, Patino LL, De Oliveira JB. Elevation of prostate specific antigen in cardiac surgery with extracorporeal cardiopulmonary circulation. J Urol. 1998;159: 875-877
9. Guvel S, Turkoz R, Egilmez T, Kilinc F, Yaycioglu O, Atalay H, et al. Does ischemia-induced prostate damage during cardiac surgery involving cardiopulmonary bypass cause bladder outlet obstruction? Urol Int. 2005;74:337-340
10. Parlaktas BS, Naseri E, Uluocak N, Elalmis AO, Erdemir F, Etikan I. Comparison of the effects of on-pump versus off-pump coronary artery bypass surgery on serum prostate-specific antigen levels. Int J Urol. 2006;13:234-237
11. Ozcan T, Gen R, Akbay E, Horoz M, Akcay B, Genctoy G, et al. The correlation of thrombolysis in myocardial infarction frame count with insulin resistance in patients with slow coronary flow. Coron Artery Dis. 2008;19:591-595
12. Patané S, Marte F. Prostate-specific antigen kallikrein and acute myocardial infarction: where we are. Where are we going? Int J Cardiol. 2009, doi:10.1016/j.ijcard.2008.12.174.
13. Taussig AS, Hurst JW, Ambrose SS, Sewell CW. Massive prostatic infarction following aortocoronary bypass surgery: a report of two cases. Clin Cardiol. 1984;7:113-116 (Pubitemid 14192190)
14. Feero P, Curtis Nickel JC, Brown P, Young I. Prostatic infarction associated with aortic and iliac aneurysm repair. J Urol. 1990;143:367-368 (Pubitemid 20066399)
15. Coker C, Sherwood RA, Crayford T, Saadeh F, Mulvin D, Brakenbury E, et al. Ischemic damage to the prostate during cardiac surgery: a clinical model. Prostate. 1997;32:85-88 (Pubitemid 27280351)
16. Mueller C, Muller B, Perruchoud AP. Biomarkers: past, present, and future. Swiss Med Wkly. 2008;138(15-16):225-229
17. Patané S, Marte F, Sturiale M, Dattilo G. ST-segment elevation and diminution of prostate-specific antigen in a patient with coronary spasm and without significant coronary stenosis. Int J Cardiol. 2009, doi:10.1016/j. ijcard.2009.02.024.
18. Charlesworth MC, Young CY, Miller VM, Tindall DJ. Kinino-genase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid. J Androl. 1999;20:220-229
19. Frenette G, Tremblay RR, Lazure C, Dube JY. Prostatic kallikrein (hk2), but not prostate-specific antigen (hk3), activates single-chain urokinase-type plasminogen activator. Int J Cancer. 1997;71:897-899 (Pubitemid 27237215)